Loading...
Xinhua Finance and Economics, Beijing, Feb. 1 (Xinhua) -- In February 2024, 227 A-share companies will face the lifting of the ban on restricted shares, with a total of about 13.09 billion shares and a lifting scale of 171.882 billion yuan, down about 24.16% month-on-month and about 24.14% year-on-year.
From the perspective of industry distribution, the market value of the electronics, medicine and biology, and power equipment industries ranked among the top three respectively. In terms of individual stocks, Yangtze River Power ranked first in terms of lifting the ban, with a market value of about 11.247 billion yuan.
In addition, a total of 19 companies and 1.072 billion restricted shares were lifted in February to celebrate the anniversary of listing, with a market value of 21.992 billion yuan, including Hunan Yuneng, Cinda Securities, Longxun and other enterprises.
More than 170 billion yuan of restricted shares were lifted in February, and Yangtze River Power and Huitai Medical were among the top in terms of lifting the ban
According to the data as of January 31, 2024, 227 stocks faced lifting in February, with a total of 13.09 billion shares, and a total market value of 171.882 billion yuan based on the closing price on January 31, 2024, a decrease of about 24.16% month-on-month and a year-on-year decrease of about 24.14%.
Figure 1: The scale of restricted shares released from February 2023 to February 2024
Specifically, the market value of Yangtze River Power has exceeded 10 billion yuan, followed by Huitai Medical and Cathay Biotech.
Yangtze Power's lifting of the ban is the largest market capitalization. On February 5, the company will release 461 million private placement shares of institutions, with a market value of about 11.247 billion yuan, accounting for 1.88% of the total share capital. On January 19, Yangtze Power released a performance report, saying that the company's total operating income in 2023 will be 78.062 billion yuan, an increase of 13.36% year-on-year, and the net profit attributable to shareholders of listed companies will be 27.389 billion yuan, an increase of 15.44% year-on-year.
Figure 2: Top 50 stocks by market capitalization in February 2024
On February 2, Huitai Medical will welcome the lifting of the ban on the restricted shares of 21.68 million original shareholders for the first time, involving shareholders including Cheng Zhenghui and Cheng Ling. The market value of the company's current round of restricted shares is about 8.457 billion yuan, accounting for about 32.43% of the total share capital.
The third-largest company by market capitalization lifted in February is Cathay Biotech. Cathay Biotech lifted a total of 180 million shares, accounting for 30.82% of the total share capital, with a market value of about 7.887 billion yuan.
In addition, Wang Li Security, Hengerda and other five companies in February lifted a relatively high proportion of shares, to be lifted shares accounted for more than 70% of the total share capital.
The electronics, medicine and biology, and power equipment industries are among the top in terms of market capitalization
From the perspective of the market value of various industries, electronics, medicine and biology, and power equipment sectors rank among the top three. In terms of electronics, Baoming Technology, Feile Audio, and Huahong Company have the highest market value of lifting the ban. In terms of the pharmaceutical and biological sector, Huitai Medical, Yirui Biotechnology, and Haitai Xinguang have the highest market value of the lifting of the ban.
Figure 3: Top 10 sectors by market capitalization in February 2024
In February, a total of 19 companies celebrated the anniversary of their listing, with a total of about 1.072 billion shares and a market value of about 21.992 billion yuan.
Figure 4: List of shares released on the February 2024 listing anniversary
Among them, the market value of Hunan Yuneng and Cinda Securities exceeded 5 billion yuan, accounting for a large proportion. The lifting scale of Longxun shares and Yutaiwei followed closely behind, with 1.716 billion yuan and 1.588 billion yuan respectively.
[Read Financial Report] is a column jointly created by Xinhua Finance and Bread Finance with the interpretation of financial reports of listed companies as the main content. Xinhua Finance is a national financial information platform built by Xinhua News Agency, which comprehensively covers the global stock market, foreign exchange market and bond market, and provides authoritative, professional and comprehensive financial information services.
Editor: Wang Yuanyuan
Statement: Xinhua Finance is a national financial information platform undertaken by Xinhua News Agency. In any case, the information published on this platform does not constitute investment advice. If you have any questions, please contact customer service: 400-6123115